These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 3926492)
1. Characterization of the high-affinity interaction between human plasminogen and pro-urokinase. Lijnen HR; Zamarron C; Collen D Eur J Biochem; 1985 Jul; 150(1):141-4. PubMed ID: 3926492 [TBL] [Abstract][Full Text] [Related]
2. A transitional state of pro-urokinase that has a higher catalytic efficiency against glu-plasminogen than urokinase. Liu JN; Pannell R; Gurewich V J Biol Chem; 1992 Aug; 267(22):15289-92. PubMed ID: 1639775 [TBL] [Abstract][Full Text] [Related]
3. The effects of fibrinogen and its cleavage products on the kinetics of plasminogen activation by urokinase and subsequent plasmin activity. Lucas MA; Straight DL; Fretto LJ; McKee PA J Biol Chem; 1983 Oct; 258(20):12171-7. PubMed ID: 6226655 [TBL] [Abstract][Full Text] [Related]
4. Fragment E-2 from fibrin substantially enhances pro-urokinase-induced Glu-plasminogen activation. A kinetic study using the plasmin-resistant mutant pro-urokinase Ala-158-rpro-UK. Liu JN; Gurewich V Biochemistry; 1992 Jul; 31(27):6311-7. PubMed ID: 1385727 [TBL] [Abstract][Full Text] [Related]
5. Activation of plasminogen by pro-urokinase. II. Kinetics. Collen D; Zamarron C; Lijnen HR; Hoylaerts M J Biol Chem; 1986 Jan; 261(3):1259-66. PubMed ID: 2935529 [TBL] [Abstract][Full Text] [Related]
6. Assembly of urokinase receptor-mediated plasminogen activation complexes involves direct, non-active-site interactions between urokinase and plasminogen. Ellis V; Whawell SA; Werner F; Deadman JJ Biochemistry; 1999 Jan; 38(2):651-9. PubMed ID: 9888805 [TBL] [Abstract][Full Text] [Related]
7. Influence of cyanogen-bromide-digested fibrinogen on the kinetics of plasminogen activation by urokinase. Lijnen HR; Van Hoef B; Collen D Eur J Biochem; 1984 Nov; 144(3):541-4. PubMed ID: 6489341 [TBL] [Abstract][Full Text] [Related]
8. The effect of the carboxy-terminal lysine of urokinase on the catalysis of plasminogen activation. Lenich C; Pannell R; Gurewich V Thromb Res; 1991 Oct; 64(1):69-80. PubMed ID: 1776140 [TBL] [Abstract][Full Text] [Related]
9. A battery of monoclonal antibodies that induce unique conformations to evolve cryptic but constitutive functions of plasminogen. Madoiwa S; Arai K; Ueda Y; Ishizuka M; Mimuro J; Asakura S; Matsuda M; Sakata Y J Biochem; 1997 Feb; 121(2):278-87. PubMed ID: 9089401 [TBL] [Abstract][Full Text] [Related]
10. Kinetic analyses of the activation of Glu-plasminogen by urokinase in the presence of fibrin, fibrinogen or its degradation products. Watahiki Y; Takada Y; Takada A Thromb Res; 1987 Apr; 46(1):9-18. PubMed ID: 3590117 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor. Lijnen HR; De Cock F; Collen D Eur J Biochem; 1994 Sep; 224(2):567-74. PubMed ID: 7925373 [TBL] [Abstract][Full Text] [Related]
12. Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160. Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D Eur J Biochem; 1988 Nov; 177(3):575-82. PubMed ID: 2973984 [TBL] [Abstract][Full Text] [Related]
13. Evidence that the conformation of unliganded human plasminogen is maintained via an intramolecular interaction between the lysine-binding site of kringle 5 and the N-terminal peptide. Cockell CS; Marshall JM; Dawson KM; Cederholm-Williams SA; Ponting CP Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):99-105. PubMed ID: 9639568 [TBL] [Abstract][Full Text] [Related]
14. The blockage of the high-affinity lysine binding sites of plasminogen by EACA significantly inhibits prourokinase-induced plasminogen activation. Sun Z; Chen YH; Wang P; Zhang J; Gurewich V; Zhang P; Liu JN Biochim Biophys Acta; 2002 Apr; 1596(2):182-92. PubMed ID: 12007600 [TBL] [Abstract][Full Text] [Related]
15. A monoclonal antibody to the epsilon-aminocaproic acid binding site on the kringle 4 region of human plasminogen that accelerates the activation of Glu1-plasminogen by urokinase. Cummings HS; Castellino FJ Arch Biochem Biophys; 1985 Feb; 236(2):612-8. PubMed ID: 2982318 [TBL] [Abstract][Full Text] [Related]
16. Kinetic studies of three different molecular forms of urokinase for the activation of native human plasminogen. Toki N; Takasugi S; Sumi H Enzyme; 1981; 26(4):221-4. PubMed ID: 6788545 [TBL] [Abstract][Full Text] [Related]
18. Purification and properties of a plasminogen activator from cultured rat prostate adenocarcinoma cells. Strickland DK; de Serrano VS; Chan SY; Pollard M; Castellino FJ Biochemistry; 1983 Sep; 22(19):4444-9. PubMed ID: 6684952 [TBL] [Abstract][Full Text] [Related]
19. Kinetics of reciprocal pro-urokinase/plasminogen activation--stimulation by a template formed by the urokinase receptor bound to poly(D-lysine). Petersen LC Eur J Biochem; 1997 Apr; 245(2):316-23. PubMed ID: 9151959 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the intrinsic fibrinolytic properties of pro-urokinase through a study of plasmin-resistant mutant forms produced by site-specific mutagenesis of lysine(158). Gurewich V; Pannell R; Broeze RJ; Mao J J Clin Invest; 1988 Dec; 82(6):1956-62. PubMed ID: 2974047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]